Following the completion of its $20m funding round, Propeller Health has partnered with Aptar Pharma to expand its digital therapeutics software to a larger range of medical devices. Aptar is investing $10 million as part of a $20 million funding round, which includes returning investors Social Capital, Hikma Ventures (the venture arm of Jordan’s Hikma Pharmaceuticals) and SR One (the VC arm of GlaxoSmithKline). Aptar is one of the largest manufacturers of drug-delivery devices and committed $10m. Propeller has now raised $65.5m and supports 25,000 people with its US regulator-approved digital asthma management programmes. The company also announced that it will be working on an app for Android smartphones which allows users to track their progress in managing asthma.
Following the completion of its $20m funding round, Propeller Health has partnered with Aptar Pharma to expand its digital therapeutics software to a larger range of medical devices. Aptar is one of the largest manufacturers of drug-delivery devices and committed $10m. Propeller has now raised $65.5m and supports 25,000 people with its US regulator-approved digital asthma management programmes. The company also announced that it will be working on an app for Android smartphones which allows users to track their progress in managing asthma.